Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2019-12-02 2019-11-15
Drug Identification Number 02454025 02454025
Brand name MAR-ATORVASTATIN MAR-ATORVASTATIN
Common or Proper name ATORVASTATIN ATORVASTATIN
Company Name MARCAN PHARMACEUTICALS INC MARCAN PHARMACEUTICALS INC
Ingredients ATORVASTATIN ATORVASTATIN
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 500 TABLET 500 TABLET
ATC code C10AA C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-11-14 2019-11-14
Actual start date 2019-11-14 2019-11-14
Estimated end date 2019-12-09 2019-12-03
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments